A unique platform for you to showcase your pharmaceutical expertise, network with Indian businesses and develop your trading relationship with key Indian counterparts at Gujarat’s flagship event. The visit will include 4 days in market starting with Ahmedabad, the state’s largest city and life sciences hub, before moving onto Mumbai, the commercial capital of India.

First held in January 2003, and inaugurated by then-Chief Minister Narendra Modi, Vibrant Gujarat Global Summit is the state’s flagship event, with a focus on furthering collaborations between Gujarati and other Indian businesses, and partners from overseas. Set to host over 10,000 delegates from India and around the world, the biennial summit is now a global business hub, and is the ideal place to network not only with businesses in Gujarat, but also those from other states across India.

This year’s summit will be opened by Indian Prime Minister Narendra Modi and demonstrates the level of focus that India as a whole places on this important event.

Further information on the summit can be found here.

India, a growing pharmaceutical market

Driven by increasing consumer spending, rapid urbanisation and rising levels of healthcare insurance cover, the Indian pharmaceutical industry is expected to grow by over 15% per year between 2015 and 2020, by which point the market is expected to be worth $55 bn. Globally, the Indian pharmaceutical sector accounts for about 2.4% of the total value and 10% of total volume. India’s focus today is on rural health programmes, lifesaving drugs and preventive vaccines which bodes well for the pharmaceutical companies.

For 2017, our delegation is focussed on Life Sciences with a particular emphasis on Pharmaceuticals Manufacturing Processes and Biosimilars.

Pharmaceutical manufacturing hubs in India

Gujarat and Maharashtra are the pharmaceutical manufacturing hubs in India, and together produce about 45% of pharmaceutical products in India.

Gujarat is home to:

• over 1100 formulation units
• about 400 bulk drug manufacturing units
• more than 40% of India’s contract research companies and
• 40% of pharmaceutical machinery manufacturers.

Mumbai is the commercial capital of India, and all major pharmaceutical companies are head-quartered there. Maharashtra as a whole has 3139 pharmaceutical manufacturing units with major centres in Mumbai, Thane, Tarapur, Nashik, Aurangabad and Pune. The state is also a leader in vaccine production.

Both offer massive opportunities to partner for growth in areas of research, development and commercialisation of the products and services.

Opportunities for UK businesses joining the delegation:

• Networking with life sciences businesses from Gujarat, Maharashtra and other states
• Hear from policy decision makers and experts on panel discussions
• Access to the senior management of high profile companies in India
• Space for one-to-one meetings at the UK’s exhibition pavilion and business lounge at the summit venue
• Demonstration slot for UK delegates at Ahmedabad and Mumbai
• Invitation to the networking dinner reception hosted by British Deputy High Commissioner, Gujarat
•  Priority access passes (on first-come-first basis) for the inaugural session of the Vibrant Gujarat Global Summit in presence of Indian Prime Minister Narendra Modi and the UK representative and entry to the seminars and exhibition venues

Indian buyers are particularly interested in companies with expertise in:

• Manufacturing technologies
• Drug Quality improvement technologies
• Robotics in manufacturing processes
• Innovative products and drugs

To register, please contact:

Abhishek Jha, British Deputy High Commission, Mumbai

Abhishek.jha@mobile.trade.gov.uk /+91 22 6650 2276

Bela Kuchara, British Deputy High Commission, Ahmedabad

Bela.Kuchara@fco.gov.uk / +91 79 4039 2523

Deadline to register: 20 December 2016

We have limited registrations. There is no cost for UK businesses joining the Vibrant Gujarat delegation, but delegates will pay for their own travel and stay.